A flexible graphene field-effect transistor (Gr-FET) biosensor for ultrasensitive and specific detection of miRNA without labeling and functionalization is reported. The flexible biosensor presents robust performance even after multiple cycles of bending to a cylinder with an 8 mm radius. A DNA probe is designed with partial segment complementary to target miRNA, and immobilized on the graphene surface though π−π stacking interaction. After capture of target miRNA, a Dirac point shift in Gr-FET is induced, which shows a linear relationship with the target miRNA concentration on a semi-log scale. The Gr-FET-based biosensor finishes miRNA detection in 20 min, and is able to achieve a miRNA detection limit as low as 10 fM without any functionalization and labeling. The interaction processes of DNA-graphene and DNA-miRNA are confirmed through surface-enhanced Raman scattering technology. The proposed biosensor will have prospective applications in wearable electronics for health monitoring and disease diagnosis.

Luminescent radicals have various applications because they simultaneously possess optoelectronic, electronic, and magnetic properties. Despite the development of some luminescent tris­(2,4,6-trichlorophenyl)­methyl (TTM)-based radicals, all the substituents directly attached to the TTM skeleton are electron-donating groups. Herein, the electron-withdrawing group is first attached to a p carbon of the parent TTM radical, and two novel stable open-shell adducts based on the benzimidazole unit with red-orange emission are obtained. Their photophysical properties, photochemical stabilities, and electroluminescent performances are fully investigated. Because of the introduction of the benzimidazole unit, the intramolecular charge transfer property of D–A type molecules is suppressed to a large extent, and the delocalization of the sole electron is strengthened. Both radicals exhibit largely improved photostability compared to that of the TTM core. High PL quantum yields (ΦF) of 0.39 and 0.36 in doped films are achieved, which are among the highest values for luminescent radicals. Extremely high-voltage-durable characteristic is demonstrated in the organic light-emitting diodes utilizing them as emitters. One device has a maximal external quantum efficiency that even exceeds the classical theoretical upper limit of 5%.

Monolayer molybdenum disulfide (MoS2) crystals grown on amorphous substrates such as SiO2 are randomly oriented. However, when MoS2 is grown on crystalline substrates, the crystal shapes and orientations are also influenced by their epitaxial interaction with the substrate. In this paper, we present the results from chemical vapor deposition growth of MoS2 on three different terminations of single crystal strontium titanate (SrTiO3) substrates. On SrTiO3(111), the monolayer MoS2 crystals form equilateral triangles with two main orientations, in which they align their ⟨21̅1̅0⟩-type directions (i.e., the sulfur-terminated edge directions) with the ⟨11̅0⟩-type directions on SrTiO3. This arrangement allows near-perfect coincidence epitaxy between seven MoS2 unit cells and four SrTiO3 unit cells. On SrTiO3(110), the MoS2 crystals tend to align their edges with both the ⟨11̅0⟩ and ⟨11̅2̅⟩ directions on SrTiO3 because these both provide favorable coincidence lattice registry. This distorts the crystal shapes and introduces an additional strain detectable by photoluminescence. When triangular MoS2 crystals are grown on SrTiO3(001), they again show a preference to align their edges with the ⟨11̅0⟩ directions on SrTiO3. Our observations can be explained if the interfacial van der Waals (vdW) bonding between MoS2 monolayers and SrTiO3 is greatest when maximum commensuration between the lattices is achieved. Therefore, a key finding of this paper is that the vdW interaction between MoS2 and SrTiO3 substrates determines the supported crystal shapes and orientations by epitaxial relations. Controlled crystal orientations make the growth of large sheets of MoS2 possible when there are multiple nucleation sites. This minimizes the number of grain boundaries and optimizes the electronic properties of the material, e.g., charge mobility, which is crucial for the application of monolayer MoS2 in next-generation nanoelectronic devices.

The recent outbreak of coronavirus disease 2019 (COVID-19) is highly infectious, which threatens human health and has received increasing attention. So far, there is no specific drug or vaccine for COVID-19. Therefore, it is urgent to establish a rapid and sensitive early diagnosis platform, which is of great significance for physical separation of infected persons after rapid diagnosis. Here, we propose a colorimetric/SERS/fluorescence triple-mode biosensor based on AuNPs for the fast selective detection of viral RNA in 40 minutes. AuNPs with average size of 17 nm were synthesized, and colorimetric, surface enhanced Raman scattering (SERS), and fluorescence signals of sensors are simultaneously detected based on their basic aggregation property and affinity energy to different bio-molecules. The sensor achieves a limit detection of femtomole level in all triple modes, which is 160 fM in absorbance mode, 259 fM in fluorescence mode, and 395 fM in SERS mode. The triple-mode signals of the sensor are verified with each other to make the experimental results more accurate, and the capacity to recognize single-base mismatch in each working mode minimizes the false negative/positive reading of SARS-CoV-2. The proposed sensing platform provides a new way for the fast, sensitive, and selective detection of COVID-19 and other diseases.

(Mi)RNAs are important biomarkers for cancers diagnosis and pandemic diseases, which require fast, ultrasensitive, and economical detection strategies to quantitatively detect exact (mi)RNAs expression levels. The novel coronavirus disease (SARS-CoV-2) has been breaking out globally, and RNA detection is the most effective way to identify the SARS-CoV-2 virus. Here, we developed an ultrasensitive poly- l -lysine (PLL)-functionalized graphene field-effect transistor (PGFET) biosensor for breast cancer miRNAs and viral RNA detection. PLL is functionalized on the channel surface of GFET to immobilize DNA probes by the electrostatic force. The results show that PGFET biosensors can achieve a (mi)RNA detection range of five orders with a detection limit of 1 fM and an entire detection time within 20 min using 2 μL of human serum and throat swab samples, which exhibits more than 113% enhancement in terms of sensitivity compared to that of GFET biosensors. The performance enhancement mechanisms of PGFET biosensors were comprehensively studied based on an electrical biosensor theoretical model and experimental results. In addition, the PGFET biosensor was applied for the breast cancer miRNA detection in actual serum samples and SARS-CoV-2 RNA detection in throat swab samples, providing a promising approach for rapid cancer diagnosis and virus screening.

Non-invasive early diagnosis is of great significance in disease pathologic development and subsequent medical treatments, and microRNA (miRNA) detection has attracted critical attention in early cancer screening and diagnosis. High-throughput, sensitive, economic, and fast miRNA sensing platforms are necessary to realize the low-concentration miRNA detection in clinical diagnosis and biological studies. Here, we developed an attomolar-level ultrasensitive, rapid, and multiple-miRNA simultaneous detection platform enabled by nanomaterial locally assembled microfluidic biochips. This platform presents a large linear detection regime of 1 aM–10 nM, an ultralow detection limit of 0.146 aM with no amplification, a short detection time of 35 min with multiplex miRNA sensing capability, and a small sample volume consumption of 2 μL. The detection results of five miRNAs in real samples from breast cancer patients and healthy humans indicate its excellent capacity for practical applications in early cancer diagnosis. The proposed ultrasensitive, rapid, and multiple-miRNA detection microfluidic biochip platform is a universal miRNA detection approach and an important and valuable tool in early cancer screening and diagnosis as well as biological studies.

The current outbreaking of the coronavirus SARS-CoV-2 pandemic threatens global health and has caused serious concern. Currently there is no specific drug against SARS-CoV-2, therefore, a fast and accurate diagnosis method is an urgent need for the diagnosis, timely treatment and infection control of COVID-19 pandemic. In this work, we developed a field effect transistor (FET) biosensor based on graphene oxide-graphene (GO/Gr) van der Waals heterostructure for selective and ultrasensitive SARS-CoV-2 proteins detection. The GO/Gr van der Waals heterostructure was in-situ formed in the microfluidic channel through π-π stacking. The developed biosensor is capable of SARS-CoV-2 proteins detection within 20 min in the large dynamic range from 10 fg/mL to 100 pg/mL with the limit of detection of as low as ∼8 fg/mL, which shows ∼3 × sensitivity enhancement compared with Gr-FET biosensor. The performance enhancement mechanism was studied based on the transistor-based biosensing theory and experimental results, which is mainly attributed to the enhanced SARS-CoV-2 capture antibody immobilization density due to the introduction of the GO layer on the graphene surface. The spiked SARS-CoV-2 protein samples in throat swab buffer solution were tested to confirm the practical application of the biosensor for SARS-CoV-2 proteins detection. The results indicated that the developed GO/Gr van der Waals heterostructure FET biosensor has strong selectivity and high sensitivity, providing a potential method for SARS-CoV-2 fast and accurate detection.

No abstract